PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 17,878 shares, a decline of 81.4% from the August 15th total of 95,953 shares. Based on an average daily trading volume, of 345,630 shares, the short-interest ratio is currently 0.1 days.
PharmaTher Stock Performance
OTCMKTS:PHRRF traded down $0.00 on Friday, reaching $0.04. The stock had a trading volume of 11,620 shares, compared to its average volume of 165,396. The company has a 50-day moving average of $0.04 and a 200 day moving average of $0.05. PharmaTher has a 12-month low of $0.03 and a 12-month high of $0.30.
About PharmaTher
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.
See Also
- Five stocks we like better than PharmaTher
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
